Motley Fool Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Motley Fool Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Sell	176,588 -39,880	-18%	-$2.32M	0.46%	44
2025 Q4	$11.7M	Buy	216,468 +50,403	+30%	+$2.42M	0.46%	48
2025 Q3	$7.49M	Buy	166,065 +66,489	+67%	+$3.11M	0.31%	70
2025 Q2	$4.61M	Buy	99,576 +5,179	+5%	+$254K	0.21%	93
2025 Q1	$5.76M	Buy	94,397 +2,046	+2%	+$119K	0.32%	65
2024 Q4	$5.22M	Buy	92,351 +10,767	+13%	+$602K	0.27%	76
2024 Q3	$4.32M	Buy	81,584 +2,821	+4%	+$132K	0.26%	85
2024 Q2	$3.25M	Buy	78,763 +19,084	+32%	+$854K	0.22%	88
2024 Q1	$3.24M	Buy	59,679 +3,648	+7%	+$186K	0.21%	87
2023 Q4	$2.87M	Buy	56,031 +1,428	+3%	+$75K	0.21%	89
2023 Q3	$3.17M	Buy	54,603 +4,799	+10%	+$294K	0.25%	79
2023 Q2	$3.18M	Buy	49,804 +1,220	+3%	+$81.8K	0.28%	70
2023 Q1	$3.37M	Buy	48,584 +1,486	+3%	+$105K	0.37%	63
2022 Q4	$3.39M	Sell	47,098 -1,874	-4%	-$141K	0.38%	64
2022 Q3	$3.48M	Sell	48,972 -300	-0.6%	-$21.8K	0.34%	65
2022 Q2	$3.74M	Sell	49,272 -4,833	-9%	-$368K	0.35%	66
2022 Q1	$3.95M	Sell	54,105 -3,072	-5%	-$206K	0.29%	76
2021 Q4	$3.56M	Buy	57,177 +1,417	+3%	+$83.1K	0.23%	88
2021 Q3	$3.3M	Sell	55,760 -222	-0.4%	-$14.6K	0.21%	89
2021 Q2	$3.74M	Buy	55,982 +6,809	+14%	+$444K	0.25%	84
2021 Q1	$3.1M	Sell	49,173 -3,743	-7%	-$233K	0.22%	87
2020 Q4	$3.28M	Buy	52,916 +5,050	+11%	+$311K	0.24%	82
2020 Q3	$2.86M	Buy	47,866 +6,007	+14%	+$362K	0.25%	80
2020 Q2	$2.46M	Buy	41,859 +1,710	+4%	+$102K	0.25%	73
2020 Q1	$2.24M	Buy	40,149 +490	+1%	+$29.9K	0.29%	64
2019 Q4	$2.55M	Buy	+39,659	New	+$2.27M	0.27%	66

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Motley Fool Asset Management's BMY Position: Q1 2026 in Review

Motley Fool Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q1 2026, selling an estimated $2.32M and leaving 176,588 shares worth $10.7M. The position accounts for 0.46% of the portfolio, ranked #44.

Motley Fool Asset Management first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. The position peaked at $11.7M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Motley Fool Asset Management held 176,588 shares of Bristol-Myers Squibb worth $10.7M as of Q1 2026.
Motley Fool Asset Management sold 39,880 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.32M.
Bristol-Myers Squibb made up 0.46% of Motley Fool Asset Management's portfolio in Q1 2026, its #44 holding.
Motley Fool Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
Motley Fool Asset Management's Bristol-Myers Squibb position peaked at $11.7M in Q4 2025.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Motley Fool Asset Management's 13F filing for Q1 2026, filed 12 May 2026.